Cardiotoxicity of a non-pegylated liposomal doxorubicin-based regimen versus an epirubicin-based regimen for breast cancer: The LITE (Liposomal doxorubicin–Investigational chemotherapy–Tissue doppler imaging Evaluation) randomized pilot study

Marzia Lotrionte, Giovanni Palazzoni, Antonio Abbate, Eugenia De Marco, Eleonora Mezzaroma, Silvia Di Persio, Giacomo Frati, Francesco Loperfido, Giuseppe Biondi-Zoccai
  • International Journal of Cardiology, August 2013, Elsevier
  • DOI: 10.1016/j.ijcard.2012.10.079

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Prof. Giuseppe Biondi-Zoccai